Newsroom

Latest from Rising

rising-sign-document

Press Releases

May 20, 2020InPress Releases

Rising Pharmaceuticals to Support Phase 2 Clinical Trial of Chloroquine Phosphate for Prophylaxis Against COVID-19 in Healthcare Workers at Risk for COVID-19

May 18, 2020InPress Releases

Rising Pharmaceuticals to Support Global Clinical Trial Conducted by the CROWN Collaborative (represented by Washington University School of Medicine in the US), Investigating an Innovative Approach to Protecting Essential Healthcare Workers

May 7, 2020InPress Releases

Rising Pharmaceuticals & Laurus Labs to Support a Phase 2 Randomized Clinical Trial of Hydroxychloroquine for Prophylaxis Against COVID-19 in Patients Receiving Cancer Therapy

March 27, 2020InPress Releases

Rising Pharmaceuticals and Laurus Labs Partner to Support the University of Minnesota to Explore the Prophylaxis Effect of Hydroxychloroquine in Essential Health Care Workers

March 23, 2020InPress Releases

Rising Pharma Holdings Inc.’s Statement Regarding Recent Articles

News Mentions

April 22, 2020InNews Mentions

How 13 drugmakers have responded to the COVID-19 pandemic

April 5, 2020InNews Mentions

Coronavirus treatment: how to enroll in hydroxychloroquine study

April 3, 2020InNews Mentions

Nationwide study of health practitioners, first responders examines use of anti-malarial drug to counter COVID-19

April 2, 2020InNews Mentions

Pharmaceutical Companies Lend Support to Hydroxychloroquine Clinical Trials for COVID-19

March 29, 2020InNews Mentions

Rising Pharmaceuticals and Laurus Labs Partner

Read more about Rising’s response to the COVID-19 pandemic here.

Read more about Rising’s response to the COVID-19 pandemic here.